Giuseppe Giuffrida
University of Catania
37 Papers
382 Citations
Giuseppe Giuffrida is an academic researcher from University of Catania. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 11, co-authored 37 publications.
Chat about Author
Papers
Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease.
Alfredo R. Galassi,Salvatore Azzarelli,Andrea Tomaselli,Rodi Giosofatto,Antonella Ragusa,Salvatore Musumeci,Corrado Tamburino,Giuseppe Giuffrida +7 more
TL;DR: Exercise single-photon emission tomographic scintigraphy using Tc-99m-tetrofosmin provides significant independent information on the subsequent risk of hard and soft events and yields incremental prognostic information in addition to that provided by clinical and exercise data for hard events.
101
Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease.
Salvatore Azzarelli,Alfredo R. Galassi,Rosario Foti,C. Mammana,Salvatore Musumeci,Giuseppe Giuffrida,Corrado Tamburino +6 more
TL;DR: This study shows that 99mTc-tetrofosmin SPECT is accurate in the detection of coronary artery disease, however, the relation of the severity of scintigraphic impaired myocardial perfusion and angiographic coronary artery stenosis may differ significantly in patients with proximal stenosis of different severity.
35
Usefulness of exercise tomographic myocardial perfusion imaging for detection of restenosis after coronary stent implantation.
Alfredo R. Galassi,Rosario Foti,Salvatore Azzarelli,Giuseppe Coco,Giovanni Condorelli,Giovanni Russo,Salvatore Musumeci,Corrado Tamburino,Giuseppe Giuffrida +8 more
TL;DR: To assess the accuracy of exercise technetium99m (Tc-99m)-tetrofosmin single-photon emission tomography (SPECT) for detecting restenosis after coronary stent implantation, 97 patients who, after successful stenting procedures in native coronary arteries, prospectively underwent SPECT scintigraphy and coronary angiography were assessed.
32
A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, versus aspirin in prevention of angiographic restenosis after coronary artery Palmaz-Schatz stent implantation.
Alfredo R. Galassi,Corrado Tamburino,Nicosia A,Giovanni Russo,Grassi R,Alfio Monaco,Giuseppe Giuffrida +6 more
TL;DR: Treatment with trapidil seems to be associated with a similar incidence of stent restenosis and adverse cardiac events as compared to aspirin and could be a valuable alternative to aspirin in the setting of coronary stenting.
31